414 related articles for article (PubMed ID: 33003340)
1. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson's Disease.
Wang R; Sun H; Wang G; Ren H
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003340
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
Harrison IF; Dexter DT
Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Histone Acetylation by Autophagy in Parkinson Disease.
Park G; Tan J; Garcia G; Kang Y; Salvesen G; Zhang Z
J Biol Chem; 2016 Feb; 291(7):3531-40. PubMed ID: 26699403
[TBL] [Abstract][Full Text] [Related]
4. Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
Harrison IF; Smith AD; Dexter DT
Neurosci Lett; 2018 Feb; 666():48-57. PubMed ID: 29273397
[TBL] [Abstract][Full Text] [Related]
5. Genome-scale analysis of regulatory protein acetylation enzymes from photosynthetic eukaryotes.
Uhrig RG; Schläpfer P; Mehta D; Hirsch-Hoffmann M; Gruissem W
BMC Genomics; 2017 Jul; 18(1):514. PubMed ID: 28679357
[TBL] [Abstract][Full Text] [Related]
6. Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress.
Shi H; Deng HX; Gius D; Schumacker PT; Surmeier DJ; Ma YC
Hum Mol Genet; 2017 May; 26(10):1915-1926. PubMed ID: 28369333
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Protein Lysine Acetyltransferases in Escherichia coli.
Christensen DG; Meyer JG; Baumgartner JT; D'Souza AK; Nelson WC; Payne SH; Kuhn ML; Schilling B; Wolfe AJ
mBio; 2018 Oct; 9(5):. PubMed ID: 30352934
[TBL] [Abstract][Full Text] [Related]
8. Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson's Disease Patients.
Yakhine-Diop SMS; Niso-Santano M; Rodríguez-Arribas M; Gómez-Sánchez R; Martínez-Chacón G; Uribe-Carretero E; Navarro-García JA; Ruiz-Hurtado G; Aiastui A; Cooper JM; López de Munaín A; Bravo-San Pedro JM; González-Polo RA; Fuentes JM
Mol Neurobiol; 2019 Apr; 56(4):2466-2481. PubMed ID: 30032424
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain.
Toker L; Tran GT; Sundaresan J; Tysnes OB; Alves G; Haugarvoll K; Nido GS; Dölle C; Tzoulis C
Mol Neurodegener; 2021 May; 16(1):31. PubMed ID: 33947435
[TBL] [Abstract][Full Text] [Related]
10. Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics.
Ali I; Conrad RJ; Verdin E; Ott M
Chem Rev; 2018 Feb; 118(3):1216-1252. PubMed ID: 29405707
[TBL] [Abstract][Full Text] [Related]
11. Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.
Li P; Ge J; Li H
Nat Rev Cardiol; 2020 Feb; 17(2):96-115. PubMed ID: 31350538
[TBL] [Abstract][Full Text] [Related]
12. Sirtuin dysregulation in Parkinson's disease: Implications of acetylation and deacetylation processes.
Dhiman S; Mannan A; Taneja A; Mohan M; Singh TG
Life Sci; 2024 Apr; 342():122537. PubMed ID: 38428569
[TBL] [Abstract][Full Text] [Related]
13. Protein acetylation and deacetylation in plant-pathogen interactions.
Wang J; Liu C; Chen Y; Zhao Y; Ma Z
Environ Microbiol; 2021 Sep; 23(9):4841-4855. PubMed ID: 34398483
[TBL] [Abstract][Full Text] [Related]
14. Building a KATalogue of acetyllysine targeting and function.
Downey M; Baetz K
Brief Funct Genomics; 2016 Mar; 15(2):109-18. PubMed ID: 26512033
[TBL] [Abstract][Full Text] [Related]
15. Deacetylation of nonhistone proteins by HDACs and the implications in cancer.
Peng L; Seto E
Handb Exp Pharmacol; 2011; 206():39-56. PubMed ID: 21879445
[TBL] [Abstract][Full Text] [Related]
16. Assays to Study Enzymatic and Non-Enzymatic Protein Lysine Acetylation In Vitro.
Graf LG; Vogt R; Blasl AT; Qin C; Schulze S; Zühlke D; Sievers S; Lammers M
Curr Protoc; 2021 Nov; 1(11):e277. PubMed ID: 34748287
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson's disease.
Yang Y; Zhang S; Guan J; Jiang Y; Zhang J; Luo L; Sun C
Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166365. PubMed ID: 35158021
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.
Gleave JA; Arathoon LR; Trinh D; Lizal KE; Giguère N; Barber JHM; Najarali Z; Khan MH; Thiele SL; Semmen MS; Koprich JB; Brotchie JM; Eubanks JH; Trudeau LE; Nash JE
Neurobiol Dis; 2017 Oct; 106():133-146. PubMed ID: 28673739
[TBL] [Abstract][Full Text] [Related]
19. Histone H3 acetylation in the postmortem Parkinson's disease primary motor cortex.
Gebremedhin KG; Rademacher DJ
Neurosci Lett; 2016 Aug; 627():121-5. PubMed ID: 27241718
[TBL] [Abstract][Full Text] [Related]
20. Lysine deacetylases and mitochondrial dynamics in neurodegeneration.
Guedes-Dias P; Oliveira JM
Biochim Biophys Acta; 2013 Aug; 1832(8):1345-59. PubMed ID: 23579074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]